AUDREY MORGAN: Open Payments
NPI 1124403332 · SALEM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 40 payments from 10 companies in 2025. Trend: 2023 $147 · 2024 $1,110 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $276 |
| AstraZeneca Pharmaceuticals LP | 9 | $171 |
| Lilly USA, LLC | 6 | $126 |
| PFIZER INC. | 4 | $103 |
| Lundbeck LLC | 3 | $67 |
| Novo Nordisk Inc | 2 | $46 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
Products named: UBRELVY, NURTEC ODT, FARXIGA, BREZTRI, JARDIANCE, REXULTI, VRAYLAR, QULIPTA.
Industry payments across NH — which companies pay providers there.
